In the long human struggle against mosquito-borne illness, Malaysia finds itself in a familiar and painful position: a proven remedy exists, yet it remains out of reach for most who need it. Through mid-August 2026, the country has recorded 58,079 dengue cases and 55 deaths — a 56 percent rise over the prior year — with the burden falling hardest on Selangor and spreading into states that had long been spared. The vaccine that could blunt this outbreak sits available but largely untouched, held back not by fear or distrust, but by the quieter forces of cost, unfamiliarity, and institutional in
Malaysia's dengue surge outpaces vaccine uptake as cost and awareness lag
55 deaths recorded from dengue infections across Malaysia in 2026.
Health & Medicine